Ninevah Therapeutics

Biotechnology company focused on bringing new gene therapies to kidney patients. There are more than 450 genetic kidney diseases that are still untreated. In these cases, patients reach end-stage renal disease and require dialysis and a kidney transplant, which negatively affects their quality of life. Its aim is to discover genetic therapies with the potential to cure these patients.